Copyright
©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 103261
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103261
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103261
Table 5 Univariate and multivariate Cox regression analyses for liver failure before and after propensity score matching
Characteristics | Before PSM, univariate analyses (n = 815) | Before PSM, multivariate analyses (n = 815) | After PSM, univariate analyses (n = 662) | After PSM, univariate analyses (n = 662) | ||||||||
HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI | P | |
Group B | 2.166 | 1.288-3.643 | 0.004b | 2.523 | 1.486-4.283 | 0.001b | 2.238 | 1.284-3.901 | 0.005b | 2.241 | 1.276-3.937 | 0.005b |
Creatinine | 2.802 | 1.536-5.110 | 0.001b | 3.096 | 1.702-5.630 | < 0.001b | 2.529 | 1.287-4.970 | 0.007b | 3.12 | 1.500-6.486 | 0.002b |
Right hepatic venous wedge pressure | 2.614 | 1.223-5.586 | 0.013a | 2.643 | 1.229-5.680 | 0.013a | 1.941 | 0.858-4.392 | 0.112 | |||
Alanine aminotransferase | 1.45 | 0.979-2.146 | 0.064 | 1.683 | 1.091-2.598 | 0.019a | 1.541 | 1.003-2.366 | 0.048a | |||
Cancer antigen 153 | 0.727 | 0.484-1.092 | 0.124 | 0.814 | 0.511-1.299 | 0.389 | ||||||
Platelet count | 1.265 | 0.893-1.794 | 0.186 | 1.261 | 0.855-1.859 | 0.242 | ||||||
Carcinoembryonic antigen | 0.877 | 0.639-1.202 | 0.414 | 0.852 | 0.597-1.218 | 0.38 | ||||||
C-Reactive protein | 1.166 | 1.049-1.296 | 0.004b | 1.138 | 1.022-1.267 | 0.019a | ||||||
Alkaline phosphatase | 1.461 | 0.909-2.348 | 0.117 | |||||||||
Pre-TIPS right atrial pressure | 1.595 | 0.882-2.884 | 0.123 | |||||||||
International normalized ratio | 0.283 | 0.044-1.845 | 0.187 | |||||||||
Blood ammonia | 0.704 | 0.440-1.129 | 0.145 | |||||||||
Pre-TIPS MELD score | 0.6 | 0.024-14.884 | 0.755 | |||||||||
Activated partial thromboplastin time | 2.952 | 0.880-9.905 | 0.08 | |||||||||
Hemoglobin | 2.551 | 0.903-7.205 | 0.077 |
- Citation: Wang ZB, Zhu B, Meng MM, Wu YF, Zhang Y, Li DZ, Tian H, Wang FC, Lv YF, Ye QX, Liu FQ. Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients. World J Hepatol 2025; 17(3): 103261
- URL: https://www.wjgnet.com/1948-5182/full/v17/i3/103261.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i3.103261